SCHEMBL3921973

SCHEMBL3921973

COc1ccc2c(OC(C)=O)coc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 5/20 0.53
LMNA P02545 2/20 0.53
ALDH1A1 P00352 4/20 0.52
KDM4E B2RXH2 4/20 0.52
TP53 P04637 2/20 0.52
CYP3A4 P08684 2/20 0.52
HSD17B10 Q99714 1/20 0.52
NPC1 O15118 4/20 0.51
KMT2A Q03164 3/20 0.51
RAB9A P51151 5/20 0.50
MAPT P10636 4/20 0.50
POLB P06746 2/20 0.49
APOBEC3A P31941 1/20 0.49
CTDSP1 Q9GZU7 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
XDH P47989 1/20 0.49
TSHR P16473 1/20 0.49
HTT P42858 1/20 0.49
PIN1 Q13526 1/20 0.49
BACE1 P56817 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502413 0.91 KDM4E (0.59) SMN1; SMN2LMNAALDH1A1KDM4ETP53
SCHEMBL15211199 0.86 NPC1 (0.51) SMN1; SMN2LMNAALDH1A1KDM4ETP53
SCHEMBL437186 0.81 KMT2A (0.51) SMN1; SMN2LMNAALDH1A1KDM4ETP53
SCHEMBL12099914 0.81 MAPT (0.51) SMN1; SMN2LMNAALDH1A1KDM4ECYP3A4
SCHEMBL31493875 0.80 ABCB11 (0.48) SMN1; SMN2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL12164332 0.80 ABCB11 (0.48) SMN1; SMN2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL15897821 0.80 ALDH1A1 (0.46) SMN1; SMN2LMNAALDH1A1KDM4EHSD17B10
SCHEMBL12687295 0.80 KDM4E (0.42) SMN1; SMN2LMNAALDH1A1KDM4ETP53
SCHEMBL18550763 0.80 POLB (0.69) SMN1; SMN2LMNAALDH1A1KDM4ECYP3A4
SCHEMBL246219 0.79 KDM4E (0.62) SMN1; SMN2LMNAALDH1A1KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112955142-A Functionalized heterocyclic compounds as antiviral agents 英安塔制药有限公司 2021-06-11 CN disclosed
EP-2248812-B1 FUSED CYCLIC COMPOUNDS AS GPR40 RECEPTOR MODULATORS TAKEDA PHARMACEUTICAL (JP) 2013-12-25 EP disclosed
EP-2041123-A2 FUSED CYCLIC COMPOUNDS Takeda Pharmaceutical Company Limited (JP) 2009-04-01 EP disclosed
WO-2008001931-A2 FUSED CYCLIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-01-03 WO disclosed